Skip to content

Clinical trials

Completed Phase 1 Myeloproliferative Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Phase: Phase 1 Status: Completed Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20013
20025
20033
20043
20057
20064
20073
20082
20092
20103
20111
20121
20132
20171
20182
20191
20201
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed64

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)12
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins8
Memorial Sloan Kettering Cancer Center5
M.D. Anderson Cancer Center3
Northwestern University3
California Cancer Consortium2
Case Comprehensive Cancer Center2
Fred Hutchinson Cancer Center2
Indiana University2
Vion Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders64
Leukemia, Myeloid, Acute49
Precursor Cell Lymphoblastic Leukemia-Lymphoma47
Leukemia, Myelomonocytic, Chronic41
Leukemia39
Myelodysplastic Syndromes39
Leukemia, Lymphocytic, Chronic, B-Cell37
Lymphoma, Non-Hodgkin31
Primary Myelofibrosis31
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative30

Trials

Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.